±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 2105  |  »Ø¸´: 2

¼«ÀÖÎ÷·½

½ð³æ (³õÈëÎÄ̳)

[ÇóÖú] ÇëÎÊdrug@fdaºÍorange bookÓÐÊ²Ã´Çø±ð£¿ÀïÃæµÄÊÕ¼ҩÎïµÄ×ÜÁ¿Ë­¶à£¿ ÒÑÓÐ1È˲ÎÓë

×î½ü²éµÄÒ©ÎïÓÐЩÔÚdrug@fdaÓжøÔÚorange bookÀïûÓС£¡£¡£¡£
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

trsdfae

гæ (СÓÐÃûÆø)


Ò©ÎïÆµµÀºÍ³ÈƤÊéÓб¾ÖÊÉϵÄÇø±ð
2Â¥2014-12-11 08:48:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xujun9998

°æÖ÷ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
¼«ÀÖÎ÷·½: ½ð±Ò+4, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2014-12-16 14:28:47
Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations   
FDA³ÈƤÊé¼´orange book£¬ÊÕ¼¾­ÓÉFDAÉóÅúµÄÈ«²¿Ò©Æ·£¬Ò²¼´¡¶¾­¹ýÖÎÁƵÈͬÐÔÆÀ¼ÛÅú×¼µÄÒ©Æ·¡·£¨approved drug products with therapeutic
equivalence evaluations£©¡£
³ÈƤÊéÏêϸÍêÕûµÄÁгöÁËÔÚ¡¶Ê³Æ·¡¢Ò©Æ·ºÍ»¯×±Æ··¨¡·Ö¸µ¼Ï£¬ÀúÄêÀ´¸ù¾ÝÆä°²È«ÐÔºÍÓÐЧÐÔÅú×¼µÄËùÓÐÒ©Æ·¡£ÆäÖÐ×îÖØÒªÊÇÃ÷È·ÁгöÐÂÒ©ËùÉæ¼°µÄËùÓÐרÀûÒÔ¼°Êг¡×¨Óª±£»¤ÐÅÏ¢¡£Ó¡Ë¢³ö°æµÄ¡°³ÈƤÊ顱ÔÚÿÄêÈýÔ·¢ÐУ¬½«¹ýÈ¥Ò»ÄêÄÚFDAËùÅú×¼µÄÒ©Æ·¼°ÆäרÀûºÍ±£»¤ÆäÐÅÏ¢¸üС£³ýÄê¶È¸üÐÂÍ⣬fda»¹³ö°æ¡°³ÈƤÊ顱µÄ»ýÀÛÔö¿¯£¨cumulative supplement£©£¬½«µ±Äê»ýÀÛµÄÒ©Æ·ÐÅÏ¢°´Ô¸üз¢±í¡£´ÓÒ©Æ·Åú×¼µ½ÁÐÈë³ÈƤÊ飬һ°ãÓÐÈýÖܵÄÖͺóʱ¼ä¡£

drug@fda: FDA Approved Drug Products
´ËÏîÄ¿Ãû³ÆÎª¡°Drugs @ FDA¡±£¬°üÀ¨Á˾­FDAÅú×¼µÄ´¦·½Ò©¡¢·Ç´¦·½Ò©ÒÔ¼°ÒÑ·ÏÖ¹µÄÒ©Æ·¡£¸ÄÏîĿλÓÚFDA¹Ù·½ÍøÕ¾µÄ¡°Ò©Æ·ÆÀ¼ÛºÍÑо¿ÖÐÐÄ¡±À¸Ä¿£¬
ÊǵÚÒ»¸öÄÒÀ¨ÁËÏêϸҩƷÈÏÖ¤¼Ç¼µÄÍøÂç×ÊÔ´¡£ ¡°Drugs @ FDA¡±ÏîÄ¿½«ËùÓйØÓÚÈÏÖ¤Ò©Æ·µÄÏêϸÐÅÏ¢ËѼ¯ÓÚÒ»¸öÊý¾Ý¿â£¬Óû§²»±ØÎª»ñµÃÆÕͨҩƷ»òÕ߯·ÅÆÒ©Æ·µÄÐÅÏ¢¶øËÑË÷¶à¸öÍøÒ³¡£±¾Êý¾Ý¿âËѼ¯ÁËËùÓÐÒ©Æ·ÆÀ¼ÛºÍÑо¿ÖÐÐĵÄÐÅÏ¢£¬°üÀ¨Ïû·ÑÕßÐÅÏ¢±í£¬ÓÃÒ©Ö¸ÄÏ¡¢Ò©Æ·É̱ꡢҩƷ½û¼ÉºÍҩƷȱÏݵÈÐÅÏ¢¡£ Óû§¿ÉÒÔͨ¹ýÒ©Æ·µÄÉÌÆ·Ãû»ò³É·ÖËÑË÷µ½ÆäÈÏÖ¤ÐÅÏ¢ºÍ¸ÃÒ©Æ·µÄÁÆÐ§µÈÐÅÏ¢¡£
±ÈÈ磺
   1.FDA¹ØÓÚ¸ÃÒ©µÄ×îÐÂÐÅÏ¢£¬ÓÃÒ©Ö¸Äϵȣ»
   2.¹ØÓÚÓÐÏàͬ¹¦Ð§µÄ´¦·½Ò©¡¢·Ç´¦·½Ò©ÐÅÏ¢£¬ÒÔ°ïÖúÓû§ÅжϺÎÖÖÒ©Îï×îΪºÏÊÊ£»
   3.ͨ¹ýÒ©Æ·µÄÉÌÆ·ÃûËÑË÷ÊÇ·ñÓй¦Ð§ÀàËÆµÄÒ©Æ·¡£

¹À¼ÆÓ¦¸ÃÊǺóÕßÈ«
3Â¥2014-12-11 10:10:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ¼«ÀÖÎ÷·½ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +6 ÉîVËÞÉá°É 2026-03-29 6/300 2026-03-29 20:51 by ÌÆãå¶ù
[¿¼ÑÐ] 08¹¤¿ÆÇóµ÷¼Á286 +3 tgs_001 2026-03-28 3/150 2026-03-29 18:29 by 1018329917
[¿¼ÑÐ] 340Çóµ÷¼Á +6 Amber00 2026-03-26 6/300 2026-03-29 12:06 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 356Çóµ÷¼Á +4 gysy?s?a 2026-03-28 4/200 2026-03-29 10:32 by ÌÆãå¶ù
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á£¬Çóµ¼Ê¦ÊÕ +9 ÌìÌìºÃÔËÀ´Éϰ¶° 2026-03-24 10/500 2026-03-28 22:17 by chemzp
[¿¼ÑÐ] 332Çóµ÷¼Á +4 @MZB382400 2026-03-28 4/200 2026-03-28 21:02 by ÌÆãå¶ù
[¿¼ÑÐ] 347Çóµ÷¼Á +3 ɽ¶¥¼û¦Á 2026-03-25 3/150 2026-03-28 14:13 by ÌÆãå¶ù
[¿¼ÑÐ] 346Çóµ÷¼Á Ò»Ö¾Ô¸070303Óлú»¯Ñ§ +3 Âܲ·ìÀÇà²Ë 2026-03-28 3/150 2026-03-28 14:11 by ÌÆãå¶ù
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ²ÄÁÏѧ˶Çóµ÷¼Á +3 @taotao 2026-03-28 3/150 2026-03-28 10:26 by JourneyLucky
[¿¼ÑÐ] 291Çóµ÷¼Á +6 HanBeiNingZC 2026-03-24 6/300 2026-03-28 07:55 by baoball
[¿¼ÑÐ] 086502»¯Ñ§¹¤³Ì342Çóµ÷¼Á +6 °¢Ò̸´¹Å²»¹ý 2026-03-27 6/300 2026-03-28 07:06 by wangy0907
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á£¬Ò»Ö¾Ô¸ÄÏÅ©083200ʳƷ¿ÆÑ§Ó빤³Ì +5 XQTJZ 2026-03-26 5/250 2026-03-27 14:49 by ¿ñìÅÂóµ±µ±
[¿¼ÑÐ] ¿¼Ñл¯Ñ§308·ÖÇóµ÷¼Á +10 ÄãºÃÃ÷ÌìÄãºÃ 2026-03-23 12/600 2026-03-27 14:43 by shangxh
[¿¼ÑÐ] µ÷¼Á +3 Àî¼Îͼ¡¤S¡¤Â· 2026-03-27 3/150 2026-03-27 11:19 by wangjy2002
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£´ó085600£¬310·ÖÇóµ÷¼Á +5 Àîäì¿É 2026-03-26 5/250 2026-03-27 11:14 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 324Çóµ÷¼Á +5 hanamiko 2026-03-26 5/250 2026-03-27 10:33 by wangjy2002
[˶²©¼ÒÔ°] ±±¾©ÁÖÒµ´óѧ˶µ¼ÕÐÉú¹ã¸æ +6 kongweilin 2026-03-26 8/400 2026-03-27 10:18 by FF_16
[¿¼ÑÐ] 304²ÄÁÏÇóµ÷¼Á +4 ÖÓllll 2026-03-26 4/200 2026-03-27 03:42 by wxiongid
[¿¼ÑÐ] 0703»¯Ñ§Çóµ÷¼Á +3 µ¤ÇàÄÌ¸Ç 2026-03-26 5/250 2026-03-26 20:11 by macy2011
[¿¼ÑÐ] »¯Ñ§µ÷¼ÁÒ»Ö¾Ô¸ÉϺ£½»Í¨´óѧ336·Ö-±¾¿ÆÉϺ£211 +4 СÓã°®Óлú 2026-03-25 4/200 2026-03-26 10:19 by aa331100
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û